| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |